News

Perricone MD Unveils Advanced Neuropeptide Serums for Aging Skin

Perricone MD Unveils Advanced Neuropeptide Serums for Aging Skin

Perricone MD Reintroduces the Neuropeptide Collection

Perricone MD today proudly announces the relaunch of its esteemed Neuropeptide Collection, ushering in a new realm of intelligent skincare designed to combat noticeable signs of aging. With almost three decades of unwavering research and holistic philosophies blending beauty from both the inside and outside, this refreshing collection showcases advanced formulas aimed at nurturing skin affected by time and expression.

Harnessing the Power of Neuropeptides

Central to this innovative collection is Perricone MD's profound understanding of neuropeptide science, a path pioneered by the founder Dr. Nicholas Perricone. He was among the first to integrate neuropeptides in topical skincare, emphasizing their remarkable benefits. These potent, protein-like components work to connect surface cells, significantly diminishing wrinkle depth. Infused with the brand's cutting-edge neuropeptide technology and next-gen biotech ingredients, including biomimetic growth factor peptides, the Neuropeptide Collection enhances elasticity, lift, and contour on areas typically associated with sagging.

Neuropeptide Deep Crease Serum

The Neuropeptide Deep Crease Serum focuses on high-movement areas susceptible to intense fold marks, such as frown lines, smile lines, nasolabial folds, and creases around the eyes and forehead. This serum is meticulously formulated to smooth deep-set wrinkles and enhance surface uniformity, while reinforcing the overall appearance of skin density and structural resilience. The inclusion of plant stem cells, harvested from a rare Swiss apple, synergistically work with biotech peptides to promote thickness and support a smoother, more resilient complexion.

Neuropeptide Eyelid Lift Serum

Meanwhile, the Neuropeptide Eyelid Lift Serum offers an ultra-lightweight and fast-absorbing solution tailored specifically for the delicate upper eyelid area. This specialized serum effectively smooths out eyelid creases and uneven textures, while diminishing the appearance of drooping or sagging eyelids. Over time, the eye area receives a lifted, more defined, and vibrant look. Beyond the primary peptide technology, it also incorporates Perricone MD's groundbreaking Acyl-Glutathione, which replenishes fragile skin and helps showcase a younger, smoother appearance.

Expert Testimonials on the Relaunch

"The revamped Neuropeptide Collection encapsulates the essence of what Perricone MD stands for: skincare driven by expertise, science, and impactful results," said Lance Patterson, the Global President of Perricone MD. "With decades of dedicated research propelling our neuropeptide technology, this relaunch signifies a fresh chapter for intelligent skincare that evolves with your skin. Each formulation is designed to lift, smooth, and define, precisely addressing the needs of mature skin, all with respect and proven efficacy."

Availability of the Neuropeptide Collection

The Neuropeptide Deep Crease Serum (1 US fl. oz. / $189) and the Neuropeptide Eyelid Lift Serum (0.5 US fl. oz. / $129) are now accessible through PerriconeMD.com as well as selected retail partners. Both products are crafted for suitability across all skin types, ensuring everyone can benefit from these advanced formulas.

About Perricone MD

For nearly 30 years, Perricone MD has championed a holistic skincare and wellness system encompassing diet, dietary supplements, and potent topical skincare solutions derived from extensive clinical and consumer research. The brand was established by Dr. Nicholas Perricone, a celebrated author recognized for his guiding book, The Wrinkle Cure. Dr. Perricone's legendary work redefined skincare paradigms and highlighted the benefits of maintaining a healthy lifestyle.

Perricone MD is rooted in an unwavering pursuit of innovative excellence, driven by a fierce commitment to achieve grand results. The conviction that merely being good enough is not sufficient continually motivates our efforts to uncover the potent science behind radiant skin from both inside and outside.

Frequently Asked Questions

What is the Neuropeptide Collection by Perricone MD?

The Neuropeptide Collection is a relaunch of advanced skincare products focused on lifting and reducing wrinkles, utilizing neuropeptide technology.

Who is the founder of Perricone MD?

Dr. Nicholas Perricone, an acclaimed author and skincare expert, founded Perricone MD to revolutionize skincare approaches with scientific insights.

Are the Neuropeptide serums suitable for all skin types?

Yes, both the Neuropeptide Deep Crease Serum and the Eyelid Lift Serum are formulated to be suitable for all skin types.

Where can I purchase the Neuropeptide products?

The Neuropeptide products are available on PerriconeMD.com and at select retail partners.

What are the key ingredients in the Neuropeptide serums?

The key ingredients include neuropeptides, plant stem cells, and Acyl-Glutathione, all designed to improve skin appearance and resilience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Photronics Faces Legal Heat: Key Investor Steps Now

Updated Category News Views 0

Eyes on Photronics: A Legal Quake Anytime you hear a stock price nosedive like a kamikaze just blew up its own runway, it ought to set off every investor's alarms. And if you’re tied into Photronics (NASDAQ:PLAB), buddy, it's time to catch up on what's driving this train off the rails. With a class period stretching from December 2025 through May 2026, the dish is a...

Continue Reading
Lyntris Advances KSAT Hyperion Satellite Program Milestone

Updated Category News Views 0

Lyntris and KSAT: A Technological Feat in Space Connectivity Well, if it ain't Lyntris back in the headlines again, pushing the envelope on space connectivity. If you're keeping tabs on the space tech space, there's a cracker of a development brewing. Lyntris Inc. (NYSE: LYNX) just checked off a crucial box in their playbook—the Critical Design Review, or CDR for those...

Continue Reading
Jim Morey Joins Pickleman's to Drive Expansion

Updated Category News Views 2

Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 1

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
Perspecta's Study Reveals Troubling Data Accuracy Gaps

Updated Category News Views 1

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Continue Reading
FirstEnergy's Bold Move: Dormo Joins to Boost Power

Updated Category News Views 1

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 1

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
McCann Systems Scores Big with Dual AV Awards Wins

Updated Category News Views 0

Piling Up the Accolades: McCann Systems Does It Again You know, getting industry awards can sometimes feel like counting beans, but when a company's snagging them year after year, that’s worth noting. McCann Systems is strutting its stuff with two Commercial Integrator Awards in 2026, cementing their reputation not just here in New Jersey, but across the AV industry....

Continue Reading
Money Market Funds Surge to Record $7.98 Trillion

Updated Category News Views 0

When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...

Continue Reading
Weight Loss Drugs Linked to Genetic Hair Loss in Men

Updated Category News Views 1

When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...

Continue Reading

Top 5 Most Recently Viewed Articles

Moroccan All Shares Experience Decline as Sectors Struggle

Updated Category News Views 64

The Effect of Declining Sectors on Moroccan Stocks Recent trading in Morocco reveals a slight downturn in the stock market, particularly impacting the Moroccan All Shares index, which has dipped by 0.53%. This decline is largely due to losses in several major sectors, notably beverage, real estate, and utilities. As the market evolves, investors are attentively watching...

Continue Reading
Bombardier Launches the Incredible Global 8000 Business Jet

Updated Category News Views 211

Introduction to the Global 8000 Business Jet The Global 8000 is the pinnacle of civil aviation, representing the fastest business jet ever produced. With a breathtaking top speed of Mach 0.95 and an impressive range of 8,000 nautical miles, this aircraft stands out as a revolutionary achievement in the realm of private aviation. It features the industry's lowest cabin...

Continue Reading
Exciting New Stock Option Granted by Taysha Gene Therapies

Updated Category News Views 145

Taysha Gene Therapies Grants Stock Option to New Employee DALLAS — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), an innovative biotechnology company focused on developing groundbreaking gene therapies for serious central nervous system disorders, has recently made news by granting a notable stock option. This strategic decision aims to attract and retain top talent...

Continue Reading
Engine Starter Fluid Market Growth Driven by Demand for Reliability

Updated Category News Views 108

Engine Starter Fluid Market Overview The engine starter fluid market is rapidly evolving, with a notable valuation of USD 362.8 million recorded in a recent report. This market is projected to grow significantly, reaching USD 450 million by the year 2025, representing an annual growth rate of 4.8%. Over the forecasted period from 2025 to 2035, the market is expected to...

Continue Reading
Japan's Approval of KOSTAIVE® Vaccine Marks COVID-19 Milestone

Updated Category News Views 167

Japan’s Health Ministry Approves KOSTAIVE® Vaccine In a significant step for public health, Japan's Ministry of Health, Labor and Welfare has approved the KOSTAIVE® vaccine from CSL and Arcturus Therapeutics. This cutting-edge self-amplifying mRNA COVID-19 vaccine is specifically aimed at battling the JN.1 strain of the Omicron variant. This approval underscores both...

Continue Reading